V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008215 | 190005998 | 1.83 | 82.5 | Palliative (P) | 2019-09-23 | 2020-03-28 | CARBOPLATIN + RT | 02 | null | CARBOPLATIN | 100618129 |
| 190008218 | 190005999 | 1.73 | 115 | Adjuvant (A) | 2019-05-13 | 2019-05-27 | EW EuroEwing 2012 Arm A VAI | N | N | FLUOROURACIL + IRINOTECAN | 101377729 |
| 190008223 | 190006000 | 1.46 | 57.9 | Palliative (P) | 2016-11-22 | 2016-11-29 | NIVOLUMAB | 02 | N | PEMBROLIZUMAB | 100530594 |
| 190008237 | 190006001 | 1.69 | 100 | Curative (C) | 2017-01-15 | 2017-11-14 | EW EuroEwing 2012 Arm B VDC | 02 | null | NIVOLUMAB | 101577429 |
| 190008241 | 190006002 | 1.7 | 143.8 | Neo-adjuvant (N) | 2020-11-23 | 2020-11-23 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101636878 |
| 190008242 | 190006003 | 1.76 | 76.9 | Curative (C) | 2018-01-02 | 2018-01-09 | Ipilimumab | 2 | Y | CISPLATIN + ETOPOSIDE | 101555265 |
| 190008247 | 190006004 | 1.8 | 82.8 | Curative (C) | 2021-05-01 | 2021-08-03 | EURAMOS TRIAL | 02 | null | DOXORUBICIN + OLARATUMAB | 100608967 |
| 190008264 | 190006005 | 1.85 | 47.8 | Palliative (P) | 2018-07-18 | 2018-07-27 | EURAMOS TRIAL | 02 | null | CISPLATIN + GEMCITABINE | 100399288 |
| 190008265 | 190006006 | 0 | 18.3 | null | 2017-09-02 | 2018-06-09 | EW EuroEwing 2012 Arm A VAI | 02 | Y | CAPECITABINE + OXALIPLATIN | 101201661 |
| 190008267 | 190006007 | 1.66 | 69.3 | Adjuvant (A) | 2018-01-15 | 2018-02-15 | PACLITAXEL | 02 | N | NIVOLUMAB | 101471565 |
| 190008274 | 190006008 | 1.83 | 62 | Curative (C) | 2018-09-12 | 2019-03-07 | Azacitidine | 02 | N | CAV | 101354029 |
| 190008280 | 190006009 | 1.73 | 63.75 | Adjuvant (A) | 2018-02-23 | 2018-07-24 | CARBOPLATIN + PACLITAXEL | 02 | Y | CARBOPLATIN + PACLITAXEL | 101068024 |
| 190008284 | 190006010 | 1.6 | 75.5 | Palliative (P) | 2017-03-21 | 2017-11-29 | Doxorubicin + Ifosfamide | 02 | N | PACLITAXEL | 100816262 |
| 190008291 | 190006011 | 1.83 | 100.8 | null | 2019-01-05 | 2019-01-05 | Cisplatin + Radiotherapy | 02 | null | PACLITAXEL | 100223841 |
| 190008302 | 190006012 | 0 | 77 | Palliative (P) | 2017-07-23 | 2017-12-10 | EW Rel rEECur | Y | N | CAPECITABINE | 100056856 |
| 190008310 | 190006013 | 1.61 | 115 | Curative (C) | 2017-09-15 | 2018-04-01 | null | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101569305 |
| 190008333 | 190006014 | 1.66 | 89.5 | Palliative (P) | 2017-05-05 | 2017-10-08 | CAPECITABINE + CARBOPLATIN | Y | N | CISPLATIN + RT | 100864653 |
| 190008338 | 190006015 | 1.69 | null | Palliative (P) | 2020-12-18 | 2021-01-11 | PAM x 2 pre-surgery (cycles 1&2) | 02 | null | ABEMACICLIB + FULVESTRANT | 100290628 |
| 190008339 | 190006016 | 1.56 | 21 | Curative (C) | 2020-02-02 | 2020-02-02 | Cisplatin 7 day | 02 | N | CISPLATIN | 100681399 |
| 190008345 | 190006017 | 0 | 47 | Curative (C) | 2021-07-27 | 2021-09-07 | Trial Unspecified | null | null | FLUOROURACIL + IRINOTECAN | 101552853 |
| 190008354 | 190006018 | 0 | 11.4 | Palliative (P) | 2020-08-14 | 2020-12-20 | ETOPOSIDE + IFOSFAMIDE + METHOTREXATE | N | Y | BEVACIZUMAB | 100182344 |
| 190008359 | 190006019 | 1.65 | 48.7 | Palliative (P) | 2019-05-31 | 2019-06-07 | Paclitaxel 7 day | 02 | N | CARBOPLATIN + FLUOROURACIL | 101111083 |
| 190008369 | 190006020 | 0 | 77 | Curative (C) | 2017-04-11 | 2017-04-11 | Avelumab | N | Y | CARBOPLATIN + ETOPOSIDE | 100176079 |
| 190008373 | 190006021 | 1.82 | 53.7 | Palliative (P) | 2020-08-31 | 2020-09-02 | Cisplatin | null | null | CISPLATIN | 100934867 |
| 190008393 | 190006022 | 1.2 | 65 | Neo-adjuvant (N) | 2018-12-10 | 2018-12-10 | EW EuroEwing 2012 Arm A VIDE | 02 | null | TRIAL | 100429717 |
| 190008408 | 190006023 | 0 | 50 | Neo-adjuvant (N) | 2018-10-17 | 2019-08-20 | Carboplatin AUC 2 - 5 | 02 | Y | CARBOPLATIN | 100845106 |
| 190008417 | 190006024 | 0 | 25.1 | Palliative (P) | 2018-02-20 | 2018-06-17 | TEMOZOLOMIDE | 02 | N | CVD | 100275307 |
| 190008419 | 190006025 | 1.66 | 107.9 | null | 2021-07-08 | 2021-10-12 | null | 02 | null | CAPECITABINE + OXALIPLATIN | 101356203 |
| 190008423 | 190006026 | null | 54.9 | Palliative (P) | 2021-08-01 | 2021-08-31 | Cisplatin + Radiotherapy | 02 | null | CARBOPLATIN + ETOPOSIDE | 100969447 |
| 190008428 | 190006027 | 1.76 | 91.2 | null | 2018-12-13 | 2019-04-22 | null | 02 | Y | DOXORUBICIN + OLARATUMAB | 100505133 |
| 190008436 | 190006028 | 1.9 | 72 | Palliative (P) | 2019-07-18 | 2019-10-31 | BEP 5 Day | Y | N | DOCETAXEL | 100827736 |
| 190008443 | 190006029 | 1.76 | 84.7 | 03 | 2019-08-04 | 2019-08-05 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | PACLITAXEL | 101739037 |
| 190008471 | 190006030 | 1.57 | 87.2 | Neo-adjuvant (N) | 2017-05-30 | 2017-11-18 | CAPECITABINE + OXALIPLATIN | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101383689 |
| 190008472 | 190006031 | 1.57 | 72.1 | Neo-adjuvant (N) | 2021-06-14 | 2021-08-10 | null | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL | 100406473 |
| 190008474 | 190006032 | 1.61 | 104.3 | null | 2019-01-04 | 2019-08-26 | Etoposide oral | 02 | N | CARBOPLATIN + GEMCITABINE | 101674078 |
| 190008475 | 190006033 | 0 | 38.4 | Curative (C) | 2017-06-06 | 2017-07-10 | CARBOPLATIN + PACLITAXEL | 01 | null | CARBOPLATIN + PACLITAXEL | 101600308 |
| 190008482 | 190006034 | 1.63 | 83.7 | Palliative (P) | 2017-11-29 | 2017-12-03 | GemCarbo Days 1+8 | 02 | N | CAPECITABINE + OXALIPLATIN | 100200593 |
| 190008489 | 190006035 | 0 | 31.2 | Palliative (P) | 2019-05-09 | 2019-05-12 | CISPLATIN + ETOPOSIDE | 02 | N | FLUOROURACIL + IRINOTECAN | 100544585 |
| 190008490 | 190006036 | 0 | 47 | Curative (C) | 2018-05-01 | 2018-05-01 | null | 01 | null | ABEMACICLIB + FULVESTRANT | 100139618 |
| 190008496 | 190006037 | 1.73 | 70.4 | Curative (C) | 2020-03-29 | 2020-07-09 | PACLITAXEL | 02 | null | CAPECITABINE | 100687980 |
| 190008508 | 190006038 | 1.77 | 42 | Palliative (P) | 2019-10-26 | 2019-10-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | GEMCITABINE | 100070073 |
| 190008512 | 190006039 | 0 | 68.1 | null | 2016-03-29 | 2016-10-08 | Irinotecan + Modified De Gramont | 02 | null | DOXORUBICIN + OLARATUMAB | 100893307 |
| 190008515 | 190006040 | 1.81 | 86 | Neo-adjuvant (N) | null | 2019-08-30 | Lenalidomide 25mg (Cycle 1 to 25) | null | null | DHAP | 100152508 |
| 190008529 | 190006041 | 1.66 | 43.6 | Curative (C) | 2018-04-28 | 2018-05-26 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 101165907 |
| 190008535 | 190006042 | 1.75 | 72.4 | null | 2019-12-12 | 2019-12-12 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | TEMOZOLOMIDE | 100902655 |
| 190008538 | 190006043 | 1.79 | 69.8 | Palliative (P) | 2019-04-28 | 2019-05-06 | Carboplatin + Etoposide iv&po | Y | N | CAPECITABINE + TEMOZOLOMIDE | 100795070 |
| 190008545 | 190006044 | 1.73 | 54.2 | Palliative (P) | 2017-03-02 | 2017-08-31 | CISPLATIN + GEMCITABINE | N | N | DOCETAXEL | 101346301 |
| 190008553 | 190006045 | 1.5 | 23.3 | Curative (C) | 2019-03-18 | 2019-03-27 | Cisplatin | 01 | N | CISPLATIN | 101151809 |
| 190008567 | 190006046 | 0 | 24.6 | Curative (C) | 2016-10-01 | 2017-03-24 | OST Euramos 1 Closed Trial - AP | 02 | N | PEMBROLIZUMAB | 100150432 |
| 190008572 | 190006047 | 0 | 0 | Curative (C) | 2018-11-27 | 2018-12-01 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101317442 |